Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New UTI pill tested against common antibiotic

NCT ID NCT05138822

Summary

This study tested a new oral drug, GSK3882347, for treating uncomplicated urinary tract infections (UTIs) in women. It compared the new drug to the standard antibiotic nitrofurantoin over a 5-day course. The main goals were to see if the new drug safely cleared the infection and how the body processed it.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • GSK Investigational Site

    Anniston, Alabama, 36207, United States

  • GSK Investigational Site

    Lomita, California, 90717, United States

  • GSK Investigational Site

    Modesto, California, 95350-5365, United States

  • GSK Investigational Site

    Doral, Florida, 33166, United States

  • GSK Investigational Site

    Miami, Florida, 33186, United States

  • GSK Investigational Site

    Miami Lakes, Florida, 33016-1507, United States

  • GSK Investigational Site

    Palmetto Bay, Florida, 33157, United States

  • GSK Investigational Site

    Sweetwater, Florida, 33172, United States

  • GSK Investigational Site

    Chicago, Illinois, 60643, United States

  • GSK Investigational Site

    The Bronx, New York, 10456, United States

  • GSK Investigational Site

    Smithfield, Pennsylvania, 15478, United States

  • GSK Investigational Site

    Austin, Texas, 78705, United States

  • GSK Investigational Site

    Dallas, Texas, 75230, United States

  • GSK Investigational Site

    Houston, Texas, 77061, United States

  • GSK Investigational Site

    Missouri City, Texas, 77459, United States

Conditions

Explore the condition pages connected to this study.